[go: up one dir, main page]

FI924650A - Salter av hydrazoner - Google Patents

Salter av hydrazoner Download PDF

Info

Publication number
FI924650A
FI924650A FI924650A FI924650A FI924650A FI 924650 A FI924650 A FI 924650A FI 924650 A FI924650 A FI 924650A FI 924650 A FI924650 A FI 924650A FI 924650 A FI924650 A FI 924650A
Authority
FI
Finland
Prior art keywords
acids
acid
unsubstituted
substituted
apart
Prior art date
Application number
FI924650A
Other languages
English (en)
Other versions
FI924650A0 (fi
FI112212B (fi
Inventor
Jaroslav Stanek
Joerg Frei
Giorgio Caravatti
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI924650A0 publication Critical patent/FI924650A0/fi
Publication of FI924650A publication Critical patent/FI924650A/fi
Application granted granted Critical
Publication of FI112212B publication Critical patent/FI112212B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
  • Cereal-Derived Products (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI924650A 1991-10-16 1992-10-14 Menetelmä aminoindanonien lääkeaineina käyttökelpoisten happoadditiosuolojen valmistamiseksi FI112212B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH304191 1991-10-16
CH304191 1991-10-16

Publications (3)

Publication Number Publication Date
FI924650A0 FI924650A0 (fi) 1992-10-14
FI924650A true FI924650A (fi) 1993-04-17
FI112212B FI112212B (fi) 2003-11-14

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924650A FI112212B (fi) 1991-10-16 1992-10-14 Menetelmä aminoindanonien lääkeaineina käyttökelpoisten happoadditiosuolojen valmistamiseksi

Country Status (24)

Country Link
EP (1) EP0538193B1 (fi)
JP (1) JP2788579B2 (fi)
KR (1) KR100265307B1 (fi)
AT (1) ATE145896T1 (fi)
AU (1) AU658931B2 (fi)
CA (1) CA2080545C (fi)
CY (1) CY2127B1 (fi)
CZ (1) CZ279601B6 (fi)
DE (1) DE59207617D1 (fi)
DK (1) DK0538193T3 (fi)
ES (1) ES2095444T3 (fi)
FI (1) FI112212B (fi)
GR (1) GR3021903T3 (fi)
HK (1) HK1005023A1 (fi)
HU (1) HU226954B1 (fi)
IL (1) IL103448A (fi)
MX (1) MX9205934A (fi)
NO (1) NO178108C (fi)
NZ (1) NZ244725A (fi)
RU (1) RU2081108C1 (fi)
SA (1) SA93130417B1 (fi)
SG (1) SG43185A1 (fi)
SK (1) SK279938B6 (fi)
ZA (1) ZA927957B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
JP3989543B2 (ja) * 1995-01-26 2007-10-10 ノバルティス・アクチエンゲゼルシャフト イミダゾール誘導体、その製造およびs−アデノシルメチオニンデカルボキシラーゼ(=samdc)阻害剤としてのその使用
EP1483231A1 (de) * 2002-03-04 2004-12-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue salmeterol-zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel
GT200600316A (es) * 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
DE59207617D1 (de) 1997-01-16
CA2080545A1 (en) 1993-04-17
CA2080545C (en) 2005-11-29
HU226954B1 (en) 2010-03-29
SA93130417B1 (ar) 2005-11-12
IL103448A0 (en) 1993-03-15
EP0538193A3 (en) 1993-06-16
MX9205934A (es) 1993-04-01
AU658931B2 (en) 1995-05-04
HUT63149A (en) 1993-07-28
IL103448A (en) 1998-01-04
FI924650A0 (fi) 1992-10-14
SG43185A1 (en) 1997-10-17
JP2788579B2 (ja) 1998-08-20
SK315292A3 (en) 1995-04-12
DK0538193T3 (da) 1996-12-23
EP0538193A2 (de) 1993-04-21
EP0538193B1 (de) 1996-12-04
CZ315292A3 (en) 1993-05-12
FI112212B (fi) 2003-11-14
HU9203234D0 (en) 1992-12-28
ES2095444T3 (es) 1997-02-16
KR930007896A (ko) 1993-05-20
NO178108B (no) 1995-10-16
CZ279601B6 (cs) 1995-05-17
HK1005023A1 (en) 1998-12-18
CY2127B1 (en) 2002-06-21
KR100265307B1 (ko) 2000-09-15
ZA927957B (en) 1993-04-26
ATE145896T1 (de) 1996-12-15
GR3021903T3 (en) 1997-03-31
NO924001D0 (no) 1992-10-15
JPH05239011A (ja) 1993-09-17
AU2704092A (en) 1993-04-22
NO178108C (no) 1996-01-24
NO924001L (no) 1993-04-19
SK279938B6 (sk) 1999-06-11
NZ244725A (en) 1995-05-26
RU2081108C1 (ru) 1997-06-10

Similar Documents

Publication Publication Date Title
NO934501L (no) Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
DE3671370D1 (de) Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel.
NO924001D0 (no) Salter av hydrazoner
IE890177L (en) Piperidinyl derivatives
ES2109988T3 (es) Derivados cefalosporinicos.
ES2067010T3 (es) Acidos aminoalcanodifosfonicos n-substituidos.
DE69207479D1 (de) Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
SE7709615L (sv) Sett att framstella acylerade heterocyklylkarboxylsyror
GR78890B (fi)
DK384485A (da) 1,6-naphthyridinderivater med kardilaterende virkning
DE69105069D1 (de) Verwendung einer Verbindung zur Herstellung eines Arzneimittels zur Senkung des Harnsäuregehalts des Blutes.
KR890008151A (ko) 키놀린 카르복산의 유도체
GB916139A (en) Quinazolone derivatives
FI882667A (fi) Foerfarande foer framstaellning av antibakteriska vid 7-staellningen substituerade 1-cyklopropyl-6-fluor -1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyror.
CA1268121C (en) .alpha.-ALKYL POLYOLEFINIC CARBOXYLIC ACIDS AND THEIR DERIVATIVES USEFUL IN THE TREATMENT OF PSORIASIS AND ALLERGIC REACTIONS

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG